Given its significant role in cell cycle regulation and genomic stability, BUB1B is being investigated as a potential biomarker for cancer prognosis and treatment response. Elevated levels of BUB1B expression have been correlated with poor prognosis in several cancers. Additionally, BUB1B expression levels could help predict the effectiveness of certain chemotherapies and targeted therapies, making it a valuable tool in personalized medicine.
